First personalised skin cancer vaccine enters final test phase

Libertatea.ro

Media Conglomerate: Ringier

First Patient RNA Vaccines Against Cancer Tested in London: "It's a form of personalised therapy"

A personalised cancer vaccine, with messenger RNA technology, is being tested on humans for the first time in London these days. Experts say this could be "a turning point" in the effort to permanently cure cancer, The Guardian reports. Melanoma, the type of cancer for which this vaccine is developed, affects around 132,000 people worldwide annually and is the disease with the highest mortality rate among skin cancers. Surgical intervention is c…